APUS

1.6008.05%
BC

Bennett C. Weintraub

Independent Director

Dr. Bennett C. Weintraub, Ph.D. is an Independent Director of Apimeds Pharmaceuticals US, Inc., since October 2024. He serves as the President of inThought Research (“inThought”), a healthcare business intelligence consulting firm which he founded in 2009. Dr. Weintraub has also served as the Chief Scientific Officer of inPhronesis since 2018.He is a Course Developer and Instructor at Bio4Front, Inc. He is also the Director of Research at Wolters Kluwer. Prior to this, he was employed at Noble Financial Group, Inc., Research Division. Before that, Dr. Weintraub has worked as a Financial Analyst for biotech and pharmaceutical industry sectors for many years. He also acted as the co-founder of BiotechTracker. In 2006, Dr. Weintraub joined Reuters Insight where he was responsible for analysis of drug development and medicine trends for the investment community while; his team later joined Wolters Kluwer in 2009. Dr. Weintraub became a licensed security analyst in 2004, first with Hibernia Southcoast Capital and later with Variant Research. Earlier, he was a Senior Scientific Editor at Cell and Molecular Cell uptil 2000. Dr. Weintraub received his Ph.D. in Biology from the University of California, San Diego and performed postdoctoral research at Stanford University and the John Curtin School of Medical Research in Canberra, Australia. He earned and a Bachelor of Science in Life Science from the Massachusetts Institute of Technology.

Positions